十四省（区、兵团）联盟药品集采落地陕西

Core Insights - The centralized drug procurement program in Shaanxi has been implemented, covering 216 specifications of 16 drug varieties, with an average price reduction of 51.46% [1][2] - The program is expected to save medical institutions in Shaanxi approximately 1.443 billion yuan in the first year [1] - The initiative aims to ensure a stable supply of drugs by allowing multiple companies to win bids, thus avoiding supply risks associated with single-source procurement [1] Group 1 - The procurement project is the first in Shaanxi to save over 1 billion yuan, with a focus on commonly used drugs for cardiovascular and digestive conditions [1] - A total of 202 companies participated in the bidding process, submitting 505 products, which enhances competition and ensures diverse supply [1] - For example, the price of a commonly used drug for liver disease was reduced by 4.11 yuan per unit, saving patients over 80 yuan per treatment course [1] Group 2 - The provincial government has issued execution documents to clarify responsibilities for all parties involved, ensuring timely and sufficient delivery of drugs [2] - The centralized procurement is part of broader healthcare reforms aimed at reducing inflated drug prices and improving the market environment [2] - Shaanxi plans to continue optimizing drug procurement during the 14th Five-Year Plan, expanding the range of covered products to benefit more residents [2]